234 related articles for article (PubMed ID: 23543443)
21. Relaxin-induced matrix metalloproteinase-9 expression is associated with activation of the NF-kappaB pathway in human THP-1 cells.
Ho TY; Yan W; Bagnell CA
J Leukoc Biol; 2007 May; 81(5):1303-10. PubMed ID: 17289798
[TBL] [Abstract][Full Text] [Related]
22. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
23. New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Delassus GS; Cho H; Park J; Eliceiri GL
J Cell Physiol; 2008 Dec; 217(3):739-44. PubMed ID: 18651563
[TBL] [Abstract][Full Text] [Related]
24. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
Hegedüs L; Cho H; Xie X; Eliceiri GL
J Cell Physiol; 2008 Aug; 216(2):480-5. PubMed ID: 18286480
[TBL] [Abstract][Full Text] [Related]
25. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
[TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
27. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
28. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
[TBL] [Abstract][Full Text] [Related]
29. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Fu OY; Hou MF; Yang SF; Huang SC; Lee WY
Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326
[TBL] [Abstract][Full Text] [Related]
30. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
31. S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.
Xu H; Li M; Zhou Y; Wang F; Li X; Wang L; Fan Q
Tumour Biol; 2016 Mar; 37(3):2925-32. PubMed ID: 26409452
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
[TBL] [Abstract][Full Text] [Related]
34. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
[TBL] [Abstract][Full Text] [Related]
35. The C-terminal region of S100A4 is important for its metastasis-inducing properties.
Zhang S; Wang G; Liu D; Bao Z; Fernig DG; Rudland PS; Barraclough R
Oncogene; 2005 Jun; 24(27):4401-11. PubMed ID: 15856021
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
39. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
Senolt L; Grigorian M; Lukanidin E; Simmen B; Michel BA; Pavelka K; Gay RE; Gay S; Neidhart M
Ann Rheum Dis; 2006 Dec; 65(12):1645-8. PubMed ID: 17105852
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4.
Elenjord R; Ljones H; Sundkvist E; Loennechen T; Winberg JO
Connect Tissue Res; 2008; 49(3):185-8. PubMed ID: 18661339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
